Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Early test checks heart safety of potential monthly HIV pill

NCT ID NCT07063238

Summary

This early-stage study tested whether a very high dose of an experimental monthly pill for preventing HIV could affect heart rhythm. The trial involved 42 healthy adults and compared the pill's effects to a placebo and a known heart medication. The main goal was to check for any safety concerns related to the heart before further development of this potential new prevention option.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hassman Research Institute Marlton Site ( Site 0001)

    Marlton, New Jersey, 08053, United States

Conditions

Explore the condition pages connected to this study.